1AI algorae pharmaceuticals limited

oldinvestor It looks as if the UPRDS test, let alone...

  1. 8,685 Posts.
    lightbulb Created with Sketch. 867
    oldinvestor

    It looks as if the UPRDS test, let alone intra-observer error, is too lacking in precision to be accurately used with LCT's unavoidably small samples of individuals.

    Statistical sensitivity must be considered, when the testing has its own errors.

    The concept of statistical sensitivity assesses the probability of a particular test giving the correct result, in this case the probability that the UPRDS test has correctly recognized an improvement.

    Again - I am thinking of the research field, not the passing of a Phase II examination.

    Please don't go away. Your insightful experiences are valuable here.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
0.5¢
Change
-0.001(9.09%)
Mkt cap ! $8.436M
Open High Low Value Volume
0.5¢ 0.5¢ 0.5¢ $11.21K 2.243M

Buyers (Bids)

No. Vol. Price($)
13 10434958 0.4¢
 

Sellers (Offers)

Price($) Vol. No.
0.6¢ 4199719 8
View Market Depth
Last trade - 13.45pm 17/07/2025 (20 minute delay) ?
1AI (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.